INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2019

Resveratrol shows therapeutic potential across various diseases in over 244 clinical trials and is reported safe at doses up to 5 g/day.

This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.

Study type
Narrative review of clinical trials
Who was studied
Human subjects across over 244 clinical trials (with 27 ongoing)
What was measured
Efficacy, safety, and pharmacokinetics across various chronic diseases

THE PAPER

Health benefits of resveratrol: Evidence from clinical studies.

Singh AP, Singh R, Verma SS, Rai V, Kaschula CH, Maiti P, Gupta SC. Med Res Rev, 2019.

PubMed 30741437 ↗DOI 10.1002/med.21565 ↗

Heart & arteriesDiabetes & blood sugarCancerBlood pressureKidney healthWeight & appetiteBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.